Injection Sclerotherapy held a 66.45% share of the varicose veins treatment market in 2025, reflecting its established role as a widely used treatment option across routine clinical settings. its position is supported by broad physician familiarity, consistent use in managing a wide range of visible vein conditions, and straightforward integration into standard outpatient vein care. The segment’s strong share in the varicose veins treatment market also benefits from its long-standing adoption pattern, which helps sustain procedure volumes through regular patient flow and repeat clinical preference.

Endovenous Ablation is emerging as the fastest-growing segment in the varicose veins treatment market because treatment pathways are increasingly shifting toward minimally invasive approaches that address venous insufficiency with procedural efficiency. Its momentum is tied to growing acceptance among providers seeking targeted interventions that fit modern vein treatment workflows while offering an alternative to more conventional methods. Compared with other treatment types, Endovenous Ablation is gaining traction as clinical practices align more closely with less invasive procedural models and evolving patient management preferences.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals accounted for the largest share of the varicose veins treatment market in 2025, supported by their ability to manage a broad mix of patient cases within integrated care environments. Their leading share is sustained by access to specialist teams, diagnostic capabilities, and procedural infrastructure that allow hospitals to handle both standard and more complex vein treatment requirements. This setting remains central to the varicose veins treatment market because many patients enter treatment pathways through hospital-based referral and evaluation systems.

Ambulatory Surgical Centers are the fastest-growing end-use segment in the varicose veins treatment market as providers increasingly favor efficient outpatient settings for procedures that do not require extended hospital stays. Their growth is being supported by the practical shift toward streamlined same-day treatment models, especially for minimally invasive vein procedures that can be performed with lower operational burden. Relative to hospitals and other care settings, Ambulatory Surgical Centers are gaining momentum because they align well with procedure standardization and the broader move toward outpatient specialty care.